Andere talen EuBiologics Co., Ltd.

Aandelen

A206650

KR7206650004

slotkoers Korea S.E. Andere beurzen 00:00:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13.540 ^KRW	+1,12%		-2,66%	+18,05%

29/01	Zimbabwe start huis-aan-huis choleravaccinatiecampagne	RE
2023	Pop Biotechnologies en EuBiologics' Eucorvac-19 vaccin treft doel in Fase 3 studie	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Gavi and UNICEF welcome approval of new oral cholera vaccine	19/04
Gavi and Unicef Welcome Approval of New Oral Cholera Vaccine [press release]	19/04
What's Behind the Worldwide Shortage of Cholera Vaccines? for Starters, They're Only Made By One Company [analysis]	13/03
Reservas de vacunas contra el cólera, "vacías" ante aumento de casos	14/02
Zimbabwe launches door-to-door cholera vaccination campaign	29/01
Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial	14-07-23
Gavi - Global vaccine alliance outlines path to sustainable cholera vaccine supply	23-05-23
EuBiologics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21-03-23
POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19	01-12-22
POP Biotechnologies' next-gen vaccine technology to enter COVID-19 phase III clinical trials	07-02-22
Eubiologics Co., Ltd. Announces Phase Iii Clinical Trial Ind Approval of Eucorvac-19, Covid-19 Vaccine Candidate, in South Korea	03-02-22
Clips Co., Ltd. announced that it expects to receive KRW 2.50003 billion in funding from EuBiologics Co., Ltd., SK bioscience Co.,Ltd., BNC Korea Co., Ltd.	27-01-22
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	12-04-21
EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea	21-01-21
EuBiologics Co., Ltd.(KOSDAQ:A206650) added to S&P Global BMI Index	23-09-19
ATGC Co., Ltd. announced that it has received KRW 2.1 billion in funding from EuBiologics Co., Ltd.	10-01-19
ATGC Co., Ltd. announced that it expects to receive KRW 2.1 billion in funding from EuBiologics Co., Ltd.	04-01-19
EuBiologics Co., Ltd. announced that it has received KRW 30.00000351 billion in funding	30-04-18
EuBiologics Co., Ltd. announced that it expects to receive KRW 30 billion in funding	12-02-18
Global Health Investment Fund I, LLC, managed by Global Health Investment Advisors, LLC acquired 6.19% stake in EuBiologics Co., Ltd..	02-02-17

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen EuBiologics Co., Ltd.

Aandelen

A206650

KR7206650004

Andere talen

Filters